BioSpace News Archive

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

The report also highlights about changes in the market dynamics due to outbreak of the COVID-19 pandemic.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a next generation product, into the RESCUE 3 pivotal clinical study studying faster ventilator independence.

Kerecis, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, today announced that Fertram Sigurjonsson, Kerecis Founder and CEO, and Mike Cadigan, Chief Financial Officer, will participate in meetings at SVB Leerink Annual Global Healthcare Conference.

Amnio Technology is announcing the launch of two new PalinGen® membrane products, PalinGen® Dual-Layer Membrane and Dual Layer PalinGen® X-Membrane.

PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced positive five-year results from its 181 patient randomized WATER study comparing Aquablation therapy to TURP, the historical standard of care for treating BPH.

Treace Medical Concepts, Inc., a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus, announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Thursday, March 3, 2022.

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces its operating results for the first quarter of fiscal year 2022 ended December 31, 2021.

Accuray Incorporated (NASDAQ: ARAY) announced today that Royal has selected two Radixact Systems with ClearRT™ helical fan-beam kVCT imaging and Synchrony® artificial intelligence (AI)-driven four-dimensional (4D) dynamic delivery technology to expand access to potentially life-saving radiotherapy treatments to more patients.